Aspiriant LLC’s Vanguard Russell 1000 ETF VONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
+635
New +$208K 0.01% 371
2015
Q4
Sell
-2,498
Closed -$238K 100
2015
Q3
$238K Hold
2,498
0.02% 96
2015
Q2
$238K Buy
+2,498
New +$243K 0.02% 100
2014
Q4
Sell
-5,260
Closed -$478K 99
2014
Q3
$478K Sell
5,260
-6,974
-57% -$636K 0.07% 59
2014
Q2
$1.11M Sell
12,234
-3,928
-24% -$345K 0.15% 40
2014
Q1
$1.4M Buy
+16,162
New +$1.37M 0.2% 36

Other funds holding VONE

Aspiriant LLC's VONE Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Vanguard Russell 1000 ETF (VONE) in Q2 2026: 635 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #371 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in VONE as recently as Q3 2015.

Aspiriant LLC first reported a position in VONE in Q1 2014 and has held it in 6 quarters since. The position peaked at $1.4M in Q1 2014. 408 funds tracked by Wall St. Rank hold VONE as of Q2 2026.

  • Aspiriant LLC held 635 shares of Vanguard Russell 1000 ETF worth $215K as of Q2 2026.
  • Vanguard Russell 1000 ETF was a new Aspiriant LLC position in Q2 2026.
  • Vanguard Russell 1000 ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #371 holding.
  • Aspiriant LLC first reported a position in Vanguard Russell 1000 ETF in Q1 2014 and has held it in 6 quarters since.
  • Aspiriant LLC's Vanguard Russell 1000 ETF position peaked at $1.4M in Q1 2014.
  • 408 funds tracked by Wall St. Rank held Vanguard Russell 1000 ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.